 |
|
Treatment of Status Epilepticus With Lorazepam
Robert J. Levy, MD;
Ronald L. Krall, MD
Arch Neurol. 1984;41(6):605-611.
Abstract
• Twenty-one episodes of status epilepticus (SE) were each treated with 1 to 9 mg (mean, 4 mg) of intravenous lorazepam. All patients with generalized tonicclonic (GTC) SE responded within 15 minutes. Nine (82%) of the 11 patients with episodes of partial SE with altered responsiveness responded poorly. Respiratory depression occurred in five instances (two requiring intubation) and was associated with transient loss of brain-stem reflexes, hypotension, and decorticate posturing in three cases. Generalized tonic-clonic SE was transformed into partial SE with altered responsiveness in three patients. In an additional four patients, marked lethargy developed. Lorazepam appears effective in controlling GTC SE but only occasionally effective in partial SE with altered responsiveness.
Author Affiliations
From the Department of Neurology, University of Rochester (NY) Medical Center. Dr Krall is now with the Clinical Research section, Lorex Pharmaceuticals, Skokie, Ill.
Footnotes
Accepted for publication July 21, 1983.
Reprint requests to Department of Neurology, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642 (Dr Levy).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
New Management Strategies in the Treatment of Status Epilepticus
Manno
Mayo Clin Proc. 2003;78:508-518.
ABSTRACT
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
Treiman et al.
NEJM 1998;339:792-798.
ABSTRACT
| FULL TEXT
Status Epilepticus in Children: Update and Review
Pellock
J Child Neurol 1994;9:2S27-2S35.
ABSTRACT
Lorazepam in the Treatment of Refractory Neonatal Seizures: A Pilot Study
Deshmukh et al.
Arch Pediatr Adolesc Med 1986;140:1042-1044.
ABSTRACT
|
